VANI
Vivani Medical, Inc.
NASDAQ · USHealthcareMedical - Devices
$1.35+2.27%
Price as of Jul 20, 2026
VANI growth
Vivani Medical, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- -11.3%
- EBIT
- -11.2%
- EPS
- +6.4%
- Free cash flow
- -21.6%
- Operating cash flow
- -18.3%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +60.0%
Three-year CAGR
- Revenue
- —
- EBITDA
- -13.4%
- EBIT
- -11.7%
- Net income
- -13.3%
- EPS
- +0.0%
- Free cash flow
- -19.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.